Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 23, 2019

SELL
$8.12 - $15.72 $4.19 Million - $8.11 Million
-515,960 Closed
0 $0
Q1 2019

Apr 29, 2019

SELL
$15.58 - $20.01 $1.55 Million - $1.99 Million
-99,670 Reduced 16.19%
515,960 $8.09 Million
Q4 2018

Jan 17, 2019

BUY
$14.59 - $23.84 $7.09 Million - $11.6 Million
485,900 Added 374.55%
615,630 $9.49 Million
Q3 2018

Oct 31, 2018

BUY
$21.06 - $25.65 $2.73 Million - $3.33 Million
129,730 New
129,730 $2.79 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Nippon Life Global Investors Americas, Inc. Portfolio

Follow Nippon Life Global Investors Americas, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nippon Life Global Investors Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nippon Life Global Investors Americas, Inc. with notifications on news.